Literature DB >> 14622804

Stroke and central poststroke pain in an elderly population.

D Bowsher1.   

Abstract

Questionnaires about stroke and subsequent pain were administered to 1,071 elderly subjects (median age 80 years, 537 female) by nurses. Seventy-two of the subjects (6.7%) had had completed strokes and 23 (2%) had had transient ischemic attacks. The median age at incidence of both groups was 74 years, and in both groups two thirds of the subjects were men. At least 8 (11%) of the completed stroke subjects had what seemed to be central poststroke pain (CPSP). Their median age at the time of the stroke was 77.5 years; all had a motor deficit. This age was much older than that of a hospital-referred group of 111 CPSP subjects (median age 59 years), of whom only 37% had a motor deficit. It is concluded that large numbers of elderly CPSP victims are not being referred for specialist care. With a CPSP prevalence of 11% at an average stroke age of 75 years in the United Kingdom population of about 3.5 million who are older than 75 years, there would be on the order of 18,000 individuals with CPSP (not counting many younger ones). In comparison with younger hospital-referred cases, CPSP subjects in the present survey appear to have a statistically significant (P =.003) tendency to have nonburning pain and younger ones to have burning pain.

Entities:  

Year:  2001        PMID: 14622804     DOI: 10.1054/jpai.2001.24549

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  13 in total

Review 1.  Modulating the pain network--neurostimulation for central poststroke pain.

Authors:  Koichi Hosomi; Ben Seymour; Youichi Saitoh
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

2.  Post-stroke pain hypersensitivity induced by experimental thalamic hemorrhage in rats is region-specific and demonstrates limited efficacy of gabapentin.

Authors:  Fei Yang; Han Fu; Yun-Fei Lu; Xiao-Liang Wang; Yan Yang; Fan Yang; Yao-Qing Yu; Wei Sun; Jia-Shuang Wang; Michael Costigan; Jun Chen
Journal:  Neurosci Bull       Date:  2014-11-05       Impact factor: 5.203

3.  Post-stroke shoulder pain subtypes classifying criteria: towards a more specific assessment and improved physical therapeutic care.

Authors:  Manuel Torres-Parada; Jamile Vivas; Vanesa Balboa-Barreiro; José Marey-López
Journal:  Braz J Phys Ther       Date:  2019-03-04       Impact factor: 3.377

4.  Pain following stroke: a population-based follow-up study.

Authors:  Henriette Klit; Nanna B Finnerup; Kim Overvad; Grethe Andersen; Troels S Jensen
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

5.  The Efficacy of Gabapentin in Patients with Central Post-stroke Pain.

Authors:  Omid Hesami; Kourosh Gharagozli; Nahid Beladimoghadam; Farhad Assarzadegan; Behnam Mansouri; Mohammad Sistanizad
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Prevalence and Management Challenges in Central Post-Stroke Neuropathic Pain: A Systematic Review and Meta-analysis.

Authors:  Andreas Liampas; Nikolaos Velidakis; Tiffany Georgiou; Athina Vadalouca; Giustino Varrassi; Georgios M Hadjigeorgiou; Georgios Tsivgoulis; Panagiotis Zis
Journal:  Adv Ther       Date:  2020-05-23       Impact factor: 3.845

7.  Population-based study of central post-stroke pain in Rimini district, Italy.

Authors:  William Raffaeli; Cristina E Minella; Francesco Magnani; Donatella Sarti
Journal:  J Pain Res       Date:  2013-09-17       Impact factor: 3.133

8.  Pain syndromes in hemiplegic patients and their effects on rehabilitation results.

Authors:  Nil Sayiner Caglar; Turkan Akin; Ebru Aytekin; Ece Akyol Komut; Fatma Ustabasioglu; SibelCaglar Okur; YaseminPekin Dogan; Halil İbrahim Erdem; Emine Ataoglu; EbruYilmaz Yalcinkaya
Journal:  J Phys Ther Sci       Date:  2016-03-31

9.  Functional characterization of a mouse model for central post-stroke pain.

Authors:  Simon Gritsch; Kiran Kumar Bali; Rohini Kuner; Daniel Vardeh
Journal:  Mol Pain       Date:  2016-03-08       Impact factor: 3.395

10.  Targeting brain-derived neurotrophic factor in the medial thalamus for the treatment of central poststroke pain in a rodent model.

Authors:  Hsi-Chien Shih; Yung-Hui Kuan; Bai-Chung Shyu
Journal:  Pain       Date:  2017-07       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.